Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 2,008.40
-15.40 (-0.76%)
May 15, 2026, 3:29 PM IST
Caplin Point Laboratories Company Description
Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India.
The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics, and other products.
It also operates QueTenX, an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai, India.
Caplin Point Laboratories Limited
| Country | India |
| Founded | 1990 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3,966 |
| CEO | Sridhar Ganesan |
Contact Details
Address: Ashvich Tower Chennai India | |
| Phone | 91 44 2496 8000 |
Stock Details
| Ticker Symbol | CAPLIPOINT |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE475E01026 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Sridhar Ganesan | MD and Whole Time Director |
| D. Muralidharan | Chief Financial Officer - Finance and Accounts |
| Venkatram Ganapathisu Bramanian | General Counsel, Company Secretary and Compliance Officer |
| Dr. Neelakandan K. | President - API Research & Development - Hyderabad |
| Anto Vijinth V. | Functional Head -HO, Human Resources and Admin |
| M. Sathya Narayanan | Deputy Chief Financial Officer |
| Sivakumar Balasubramanian | Plant Head - Puducherry |
| Dr. S. Gunasakaran | President of Clinical Research Operations |
| R. Dinesh | Functional Head - HO, Production Planning and Inventory Control |
| Sathish Krishnan | Vice President |